Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer's disease
European Journal of Neuroscience · 2024-06 · 59 (11) · 2915-2954
DOI: 10.1111/ejn.16336 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Neuroscience, online erschienen am 15.04.2024. Verfasst von Tanvir Ahmed. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, North South University, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Alzheimer Disease, RNA, Small Interfering, Nanoparticles. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 295 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is a neurodegenerative condition that exhibits a gradual decline in cognitive function and is prevalent among a significant number of individuals globally. The use of small interfering RNA (siRNA) molecules in RNA interference (RNAi) presents a promising therapeutic strategy for AD. Lipid nanoparticles (LNPs) have been developed as a delivery vehicle for siRNA, which can selectively suppress target genes, by enhancing cellular uptake and safeguarding siRNA from degradation. Numerous research studies have exhibited the effectiveness of LNP‐mediated siRNA delivery in reducing amyloid beta (Aβ) levels and enhancing cognitive function in animal models of AD. The feasibility of employing LNP‐mediated siRNA delivery as a therapeutic approach for AD is emphasized by the encouraging outcomes reported in clinical studies for other medical conditions. The use of LNP‐mediated siRNA delivery has emerged as a promising strategy to slow down or even reverse the progression of AD by targeting the synthesis of tau phosphorylation and other genes linked to the condition. Improvement of the delivery mechanism and determination of the most suitable siRNA targets are crucial for the efficacious management of AD. This review focuses on the delivery of siRNA through LNPs as a promising therapeutic strategy for AD, based on the available literature.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, North South University, Dhaka, Bangladesh.
ORCID-Profile: Tanvir Ahmed
Zitieren
APA
Ahmed, T. (2024). Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer's disease. European Journal of Neuroscience, 59(11), 2915-2954. https://doi.org/10.1111/ejn.16336
Vancouver
Ahmed T. Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer's disease. European Journal of Neuroscience. 2024;59(11):2915-2954. doi:10.1111/ejn.16336
BibTeX
@article{Ahmed2024,
author = {Ahmed, Tanvir},
title = {Lipid nanoparticle mediated small interfering RNA delivery as a potential therapy for Alzheimer's disease},
journal = {European Journal of Neuroscience},
year = {2024},
volume = {59},
number = {11},
pages = {2915--2954},
doi = {10.1111/ejn.16336}
}
EUVIMED